This 10-cent heart drug cuts hospitalizations by 25%

Three recent studies, led by cardiologists at the UMCG in the Netherlands, have provided evidence that a low dose of digoxin could help heart failure patients avoid hospitalization and reduce the risk of death. Heart failure is a growing health issue, with over 500,000 people in the Netherlands estimated to have the condition. The heart's inability to pump blood effectively can lead to severe symptoms and repeated hospital visits.

Current standard treatment for heart failure involves a combination of medications known as the "Fantastic Four." Digoxin, a drug that has been used for centuries, costs less than ten cents per day. Three UMCG studies have now found that adding a small dose of digoxin to the standard treatment may provide additional benefits. In one study, 1,000 heart failure patients were treated in 43 Dutch centers.

Half received a low dose of digoxin, while the other half received a placebo. While individual results were not statistically significant, combined findings from a meta-analysis indicated that digoxin reduced deaths from cardiovascular disease and worsening heart failure. The largest benefit was a 25% reduction in hospital admissions for heart failure.

The drug was found to be safe and easy to use. In another study, 288 patients who had been taking digoxin and then stopped experienced significantly more problems during the first six weeks compared to those who never took the drug. While this finding doesn't directly prove digoxin's effectiveness, researchers found the size and timing of the effect impressive.

The researchers believe these results could eventually influence heart failure treatment guidelines, making this inexpensive medication available to many more patients.